Ultrasmall Cyclodextrin‐Based Nanogels as Drug Delivery Systems
ChemistryOpen · 2026-08 · 15 (8)
DOI: 10.1002/open.70274 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemistryOpen, online erschienen am 04.08.2026. Verfasst von Andrea Cesari und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and industrial Chemistry, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Cyclodextrins, Drug Delivery Systems, Antineoplastic Agents, Drug Carriers. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union - Next Generation EU through the Italian Ministry of University and Research under PNRR - M4C2-I1.3 Project PE_00000019 ″HEAL ITALIA".
Abstract (Originalsprache)
Ultrasmall cyclodextrin‐based nanogels (CDngs) crosslinked with ethylene glycol diglycidyl ether (EGDE) were tested as drug delivery systems for poorly water‐soluble anticancer agents for the first time. Two compounds with well‐established pharmacological activity but critical solubility limitations, i.e., Osthole and Combretastatin A‐4 (CA‐4), were selected to evaluate the encapsulation capacity and performance of the nanogel platform. After preliminary screening through experimental and docking investigation, CA‐4 was chosen as the reference compound. Among the formulations developed, the CA‐4/loaded nanogel displayed the highest encapsulation efficiency (EE%). Despite a less‐than‐ideal host–guest fit, the large cavity of γ‐CD allows for efficient drug encapsulation and higher loading capacity. The optimized formulation was tested in vitro to assess both the biocompatibility of γ‐CDngs, as well as the anticancer efficacy of CA‐4 loaded γ‐CD and γ‐CDngs. We demonstrate that empty systems exhibit intrinsic biocompatibility, showing no cytotoxicity toward the A2780 cancer cell line under experimental conditions. Furthermore, the CA‐4 loaded γ‐CDngs retained and enhanced the cytotoxic properties of the free drug against this cell line, compared to the corresponding native γ‐CD. Collectively, these findings validate CDngs as a promising and innovative platform for the delivery of hydrophobic anticancer molecules and support their potential for further therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and industrial Chemistry, University of Pisa, Pisa, Italy.
- Micro and Nano Systems (MNS), Leuven (Arenberg), Leuven, Belgium.
- Graduate School of Science and Technology, Department of Materials and Life Sciences, Faculty of Science and Technology, Sophia University, Tokyo, Japan.
ORCID-Profile: Andrea Cesari, Maria Antonietta Casulli, Takeshi Hashimoto, Takashi Hayashita, Dario Puppi, Fabio Bellina
Förderung
- European Union - Next Generation EU through the Italian Ministry of University and Research under PNRR - M4C2-I1.3 Project PE_00000019 ″HEAL ITALIA"
Zitieren
APA
Cesari, A., Braccini, S., Casulli, M. A., Ishigaki, K., Hashimoto, T., Hayashita, T., Puppi, D., & Bellina, F. (2026). Ultrasmall Cyclodextrin‐Based Nanogels as Drug Delivery Systems. ChemistryOpen, 15(8). https://doi.org/10.1002/open.70274
Vancouver
Cesari A, Braccini S, Casulli MA, Ishigaki K, Hashimoto T, Hayashita T, et al. Ultrasmall Cyclodextrin‐Based Nanogels as Drug Delivery Systems. ChemistryOpen. 2026;15(8). doi:10.1002/open.70274
BibTeX
@article{Cesari2026,
author = {Cesari, Andrea and Braccini, Simona and Casulli, Maria Antonietta and Ishigaki, Kento and Hashimoto, Takeshi and Hayashita, Takashi and Puppi, Dario and Bellina, Fabio},
title = {Ultrasmall Cyclodextrin‐Based Nanogels as Drug Delivery Systems},
journal = {ChemistryOpen},
year = {2026},
volume = {15},
number = {8},
doi = {10.1002/open.70274}
}
EUVIMED